介入细胞病理医师对甲状腺细针穿刺分子检测质量的影响:4651例多中心研究
该多中心研究纳入意大利南部TIRNET网络4651例甲状腺细针穿刺(FNA)样本,按Bethesda系统分类后对不确定及以上类别集中行七基因PCR检测。结果显示,聘用介入细胞病理医师的中心分子检测不满意样本率(11.3%)低于聘用非细胞病理医师的中心(16.7%,p<.05);不同中心间突变率存在显著差异,不确定类别变异最大。
要点
- 介入细胞病理医师操作可降低分子检测不满意样本率(11.3% vs 16.7%,p<.05)。
- 不同中心甲状腺FNA突变率存在显著差异,不确定类别变异最大。
- 分子检测质量指标可用于评估本地甲状腺细胞病理实践水平。
核心结论
- 介入细胞病理医师获取的分子检测诊断材料产出更高。
- 不同中心间突变率差异可能反映细胞病理医师对显微镜标准可重复性低,尤其是不确定病例。
研究设计与样本
- 多中心研究纳入意大利南部TIRNET网络4651例甲状腺FNA样本。
- FNA由不同操作者采集,当地细胞病理医师按Bethesda系统分类。
- 对意义不明的不典型、滤泡性肿瘤、可疑恶性及恶性类别集中行基于实时PCR的七基因检测。
主要发现
- 聘用介入细胞病理医师的中心分子检测不满意FNA样本率为11.3%,低于聘用非细胞病理医师中心的16.7%(p<.05)。
- 不同当地细胞病理医师诊断的FNA突变率存在显著差异。
- 不确定类别在各中心间突变率变异百分比最高。
临床怎么用
- 可考虑由介入细胞病理医师执行甲状腺FNA以提高分子检测样本满意度。
- 可利用分子检测质量指标监测本地甲状腺细胞病理实践表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnostic accuracy of thyroid fine-needle aspiration (FNA) can be highly influenced by the technical skills of the operator performing the procedure and by interobserver variability in microscopic interpretation. This is particularly true for the indeterminate categories. Recently, molecular testing has been proposed as an ancillary tool for monitoring the performance of different thyroid cytopathology practices. The objective of this multicenter study was to evaluate the quality of different local cytopathology practices by assessing the impact of interventional cytopathologists on FNA adequacy for molecular testing and the variations in mutation rates across different health care centers operating in the Campania region. METHODS: The study included 4651 thyroid FNA samples diagnosed in different Southern Italian clinical laboratories belonging to the TIRNET (the Tiroide Network). FNA samples were collected by different proceduralists and were classified by local cytopathologists according to The Bethesda System for Reporting Thyroid Cytopathology. FNAs classified as atypia of undetermined significance, follicular neoplasm, suspicious for malignancy, and malignant were centralized for a real-time polymerase chain reaction-based, seven-gene test at the authors' institution. RESULTS: Centers that employed interventional cytopathologists obtained fewer unsatisfactory FNA samples for molecular testing (11.3%) than centers that employed noncytopathologists (16.7%; p < .05). Furthermore, a significant variation in the mutation rate was observed in FNAs diagnosed by different local cytopathologists; indeterminate categories had the highest percentage of mutation rate variability among centers. CONCLUSIONS: Interventional cytopathologists obtained higher yields of diagnostic material for molecular testing. Finally, the current results suggest that the variability in mutation rates among different centers may highlight the low reproducibility of microscopic criteria among cytopathologists, particularly for indeterminate cases.
引用
- Nacchio M, Palladino R, Vigliar E, et al. Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi-institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist. Cancer Cytopathol. 2023. PMID: 37635646. doi:10.1002/cncy.22756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。